Clinical Trial Update: Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial updating immune reconstitution comparing lopinavir/ritonavir-based HAART to efavirenz-based HAART in advanced HIV disease; terminated with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immune Deficiency Syndrome

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)
• efavirenz-based HAART (efavirenz-based antiretroviral therapy)

Snippet

Sponsor: Rush University Medical Center | Conditions: Acquired Immune Deficiency Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2014-05-29